CPG
RVMD icon

Cornerstone Planning Group’s Revolution Medicines RVMD Stock Holding History

Cornerstone Planning Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4K Buy
199
+5
+3% +$730 ﹤0.01% 481
2026
Q1 		$28.6K Buy
194
+184
+1,840% +$18.6K ﹤0.01% 554
2025
Q4 		$973 Sell
10
-9
-47% -$590 ﹤0.01% 1351
2025
Q3 		$1.73K Buy
19
+9
+90% +$352 ﹤0.01% 1197
2025
Q2 		$384 Hold
10
– – ﹤0.01% 1374
2025
Q1 		$374 Buy
+10
New +$406 ﹤0.01% 1369

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Cornerstone Planning Group's RVMD Position: Q2 2026 in Review

Cornerstone Planning Group increased its Revolution Medicines (RVMD) stake by 2.6% in Q2 2026, buying an estimated $730 and bringing the position to 199 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #481.

Cornerstone Planning Group first reported a position in RVMD in Q1 2025 and has held it in 6 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Cornerstone Planning Group held 199 shares of Revolution Medicines worth $36.4K as of Q2 2026.
  • Cornerstone Planning Group bought 5 Revolution Medicines shares in Q2 2026, an estimated $730.
  • Revolution Medicines made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #481 holding.
  • Cornerstone Planning Group first reported a position in Revolution Medicines in Q1 2025 and has held it in 6 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.